Asherman's syndrome has signifi cant reproductive implications for patients. In most case series, the rate of fertility and full term birth directly correlates to extent of disease. However, there does not seem to be a connection between number of prior curettages, nor aetiology of adhesions in predicting outcome. Without a universally accepted classifi cation system, comparison of research data and results for imaging modalities is diffi cult.
Introduction
Intrauterine adhesions are known by many names including intrauterine synechiae, uterine atresia or endometrial sclerosis. In 1948, Joseph G Asherman described an organic amenorrhoea and inactive endometrium due to stenosis of the internal os of the cervix. He named it "Amenorrhoea Traumatica (Atretica)"
1 . Asherman's follow-up paper in 1950, "Traumatic Intra-uterine Adhesions", discussed uterine adhesions causing total obliteration of the cavity 2 . Today they are most often known by the eponymous name Asherman's syndrome.
Th e true incidence of Asherman's syndrome is unclear. Estimates range from 6-40% post dilatation and curettage 3, 4 . Th e American Society for Reproductive Medicine (ASRM) estimates a frequency of 7% of secondary amenorrhoea 5 .
Classifi cation systems
Many classifi cation systems have been proposed with no clear consensus. Th e European Society of Hysteroscopy (ESH) system distinguishes based on adhesion band thickness, tubal ostia patency and degree of uterine cavity obliteration. Th e American Society for Reproductive Medicine (ASRM) also takes menstrual pattern into account, potentially off ering some prognostic information. 10 described an amenorrhoeic Zulu woman with extensive uterine adhesions. Schistosomiasis was cultured from her ovarian biopsy.
Aetiology

Diagnosis and imaging
By far the commonest presentations are amenorrhoea and infertility 11 . A history of secondary menstrual anomalies following curettage of the pregnant uterus should always arouse suspicion 12 . Th e likeliest cause of secondary amenorrhoea in this age group is pregnancy and needs to be ruled out in the fi rst instance. Other diff erentials include thyroid disease, prolactinoma, polycystic ovarian syndrome and premature ovarian failure 13 , all of which need to be excluded.
Hysteroscopy is the gold standard for diagnosis. It also has the added benefi t of allowing simultaneous adhesiolytic treatment. However, with the risks of an invasive procedure under general anaesthetic, perforation of the uterus, long waiting lists and expense to our healthcare system, other imaging modalities should be considered for screening of uterine adhesions.
A literature search on diagnostic imaging of Asherman's syndrome and intrauterine adhesions or synechiae produced no randomised controlled trials, only case series and expert opinion.
Ultrasound may be utilised with (sonohysterography) or without (standard) injection of sterile saline into the uterine cavity. Adhesions characteristically appear as "bridging bands" of tissue that distort the cavity. Filmy adhesions are described as thin, undulating membranes that are most easily seen on real time scanning 14 . Transvaginal ultrasound can also be useful in measuring the thickness of the endometrial lining.
Hysterosalpinography (HSG) is a commonly used fi rst line investigation of uterine abnormalities and infertility. It involves injection of a radiopaque dye into the uterine cavity and x-ray evaluation the uterus and fallopian tubes. Adhesions are seen as fi lling defects that do not change with positioning.
A 1994 study by Raziel, et al. prospectively compared hysterosalpingogram and hysteroscopy for investigation of recurrent miscarriages. 106 patients suff ering from recurrent miscarriages were studied. Th e sensitivity of HSG for detecting uterine abnormalities was 79%, with a false positive rate of 38%. Th is was especially prevalent in the intrauterine adhesions group. Th is result is frequently reproduced in the literature.
Salle, et al. 15 conducted a small retrospective study of 19 patients with suspected intrauterine adhesions in 1997. All patients underwent transvaginal ultrasound (TVS), sonohysterography (SHG) and hysterosalpingography (HSG) screening prior to hysteroscopic treatment of adhesions. TVS had poor sensitivity and specifi city. SHG and HSG were both found to have a high sensitivity with complete correlation between the two imaging modalities.
In 2000, a prospective study of 65 infertile women by Soares, et al. 16 compared the same imaging modalities with hysteroscopy (gold standard) for diagnosis of uterine cavity diseases. Th e women were aged between 19 and 43 with 52.3% having primary infertility and 47.7% having secondary infertility. TVS failed to detect any cases of intrauterine adhesions, and in fact gave three false positive diagnoses. HSG and SHG both returned a sensitivity of 75.0% and a positive predictive value of 50.0% and 42.9% respectively. SHG also yielded one more false positive result than HSG. Negative predictive value of both was 98.3%, with 95% confi dence interval above 90. Th e authors attributed the false-positive results to possible misinterpretation of artefacts produced by air bubbles or cervical mucus injected into the uterine cavity. One complication of pelvic infl ammatory disease was documented post SHG.
3D ultrasound allows for real time visualisation and provides more accurate assessment than traditional 2D ultrasound imaging.
A case series by Cohen, et al. studied 54 women with a primary diagnosis of Asherman's syndrome and compared 3D ultrasound to hysterosalpingogram for evaluation of diagnostic accuracy. Sensitivity was calculated using hysteroscopy as the gold standard. 100% of pre-operative 3D imaging was found to be consistent with hysteroscopy results in assessing severity of disease, compared to 66.7% for HSG. It provided a more precise map of intrauterine adhesions and also enabled diff erentiation between severe intrauterine disease and outfl ow tract obstruction.
Magnetic resonance imaging (MRI) has been suggested as a diagnostic tool 18 . Th us far, there is little evidence in the literature supporting the use of MRI with only three publications available.
Th e largest is a series of 4 case reports in 1995 by Bacelar, et al. 17 discussing the usefulness of MRI in patients with established adhesions where thorough hysteroscopic visualisation of the uterine cavity was not possible. Low signal intensity bands were seen on MRI, representing fi brous scar tissue. Dense adhesions and stenosis of the internal os limits the value of hysteroscopy in these cases. For therapeutic purposes, it is essential to establish healthy endometrial tissue still remains in the upper uterine cavity. Extensive dense adhesions, partial occlusion of uterine cavity, both ostia occluded (partial)
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Case report
Our patient is a 37-year-old G4 P1 who was referred to a tertiary care imaging facility for investigation of secondary infertility. Of signifi cance in her past history is a manual removal of the placenta, two fi rst trimester miscarriages and an ectopic pregnancy. Standard 2D pelvic images were obtained that revealed echogenic foci within the endometrium (Fig. 1) . A saline infused sonohysterography (SIS) was also performed in view of this fi nding. Fig. 2 demonstrates the thin, undulating membranes suggesting the diagnosis of Asherman syndrome. Th is was confi rmed on subsequent hysteroscopy.
Reproductive implications
Th e most common presentation of Asherman's syndrome is secondary infertility. Th ese patients are also at higher risk of recurrent miscarriage. In subsequent pregnancies second trimester loss, preterm delivery, incompetent cervix, uterine rupture and placenta accreta have all been reported.
Fertility post hysteroscopic lysis of adhesions is high if normal endometrial tissue is found, although gonadotropins, intrauterine insemination (IUI) or in vitro fertilisation (IVF) is sometimes necessary 18 . A large case series of uterine adhesion treated with hysteroscopy was reported by Valle, et al. 19 in 1988; retrospective analysis of 187 patients treated over 10 years. All patients had endometrial trauma, except one who had acute endometritis. 23% had mild adhesions, 51.9% had moderate adhesions, 25.1% had severe adhesions according to ASRM criteria. 161 patients had adjuvant laparoscopy, 151 patients had an IUD placed intraoperatively, all patients received antibiotics, 171 patients received conjugated oestrogen and medroxyprogesterone acetate for at least one cycle.
Of these patients, 147 achieved pregnancy, 79.7% of whom carried to full term, 18.2% ended in spontaneous miscarriage and 2.1% of which were ectopic pregnancies.
In mild cases, the conception rate was 81.3%, but only 31.9% in those with severe disease. No placenta accreta was reported. 21.6% of the moderate group and 48.9% of the severe group required repeat treatment.
Conclusion
Asherman's syndrome has signifi cant reproductive implications for patients. In most case series, the rate of fertility and full term birth directly correlates to extent of disease. However, there does not seem to be a connection between number of prior curettages, nor aetiology of adhesions in predicting outcome. 18 Without a universally accepted classifi cation system, comparison of research data and results for imaging modalities is diffi cult.
Th e high sensitivity of HSG has made it a useful screening tool for intrauterine abnormalities. Compared with hysteroscopy, HSG is a relative safe, cheaper and a less invasive test. However it can cause a great deal of patient discomfort and has the added disadvantage of ionising radiation exposure 20 . It also produces a high number of false positives and can overestimate the severity of disease.
Small studies and case reports suggest a similar rate or diagnostic superiority of SHG over HSG for identifying intrauterine adhesions. Most of the research has been conducted using 2D ultrasound. Larger studies need to be conducted to thoroughly assess the usefulness of SHG.
3D ultrasound can provide useful information on the location and extent of adhesions, therefore assisting with grading of severity. Th e benefi t of which allows more accurate prediction of prognosis and fertility outcomes. Th is could possibly be done in combination with SHG to further improve diagnostic accuracy.
Th e continual improvement of high-resolution ultrasound together with simple infusion studies could make it potentially a very valuable tool in the assessment of these women. Consequences on fertility and possible complications in future pregnancy necessitate further research and publications.
